Multiple PPI dosage form

Details for Australian Patent Application No. 2011205024 (hide)

International Classifications

Event Publications

11 August 2011 Complete Application Filed

18 August 2011 Application Open to Public Inspection

Published as AU-B-2011205024

5 July 2012 Alteration of Name

The name of the applicant has been altered to Takeda Pharmaceuticals U.S.A., Inc. Amendments

6 September 2012 Application Accepted

Published as AU-B-2011205024

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.